Search

Author/Creator Goff, Laura

1. A clinical score for neuroendocrine tumor patients under consideration for Lu-177-DOTATATE therapy. Issue 3 (March 2021)

Authors:
Das, Satya; Du, Liping; Schad, Aimee; Jain, Shikha; Jessop, Aaron; Shah, Chirayu; Eisner, David; Cardin, Dana; Ciombor, Kristen; Goff, Laura; Bradshaw, Marques; Delbeke, Dominique; Sandler, Martin; Berlin, Jordan
Journal:
Endocrine-related cancer
Issue:
Volume 28:Issue 3(2021)
Page Start:
203
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer. Issue 2 (May 2016)

Authors:
Chan, Emily; Arlinghaus, Lori R.; Cardin, Dana B.; Goff, Laura; Berlin, Jordan D.; Parikh, Alexander; Abramson, Richard G.; Yankeelov, Thomas E.; Hiebert, Scott; Merchant, Nipun; Bhaskara, Srividya; Chakravarthy, Anuradha Bapsi
Journal:
Radiotherapy and oncology
Issue:
Volume 119:Issue 2(2016:May)
Page Start:
312
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal Cancer. (April 2019)

Authors:
Saba, Nabil F.; Force, Seth; Staley, Charley; Fernandez, Felix; Willingham, Field; Pickens, Allan; Cardona, Kenneth; Chen, Zhengjia; Goff, Laura; Cardin, Dana; Lambright, Eric; Nesbitt, Jon; Krasinskas, Alyssa; Higgins, Kristin; Harvey, R. Donald; Owonikoko, Taofeek; Ramalingam, Suresh S.; Shin, ...
Journal:
American journal of clinical oncology
Issue:
Volume 42:Number 4(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer. (12th February 2014)

Authors:
Cardin, Dana B.; Goff, Laura; Li, Chung‐I; Shyr, Yu; Winkler, Charles; DeVore, Russell; Schlabach, Larry; Holloway, Melanie; McClanahan, Pam; Meyer, Krista; Grigorieva, Julia; Berlin, Jordan; Chan, Emily
Journal:
Cancer medicine
Issue:
Volume 3:Number 3(2014:Jun.)
Page Start:
572
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ). (September 2020)

Authors:
Bang, Yung-Jue; Golan, Talia; Dahan, Laetitia; Fu, Siqing; Moreno, Victor; Park, Keunchil; Geva, Ravit; De Braud, Filippo; Wainberg, Zev A.; Reck, Martin; Goff, Laura; Laing, Naomi; Mi, Gu; Oliveira, Joana M.; Wasserstrom, Heather; Lin, Chia-Chi
Journal:
European journal of cancer
Issue:
Volume 137(2020)
Page Start:
272
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗